Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40013428
Localisation
Japan
Asia
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
19/01/2023
Statut
Classification
1.5°C
Année cible
FY2030
Astellas Pharma Inc. commits to reduce absolute scope 1 and 2 GHG emissions 63% by FY2030 from a FY2015 base year. Astellas Pharma Inc. commits to reduce absolute scope 3 GHG emissions 37.5% by FY2030 from a FY2015 base year.
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
JP3942400007
LEI
529900IB708DY2HBBB35
Source : Science Based Targets initiative | Données publiques